45 related articles for article (PubMed ID: 17901069)
21. Nephronophthisis: should we target cysts or fibrosis?
Slaats GG; Lilien MR; Giles RH
Pediatr Nephrol; 2016 Apr; 31(4):545-54. PubMed ID: 26219413
[TBL] [Abstract][Full Text] [Related]
22. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
[TBL] [Abstract][Full Text] [Related]
23. Endothelin and endothelin antagonists in chronic kidney disease.
Kohan DE; Barton M
Kidney Int; 2014 Nov; 86(5):896-904. PubMed ID: 24805108
[TBL] [Abstract][Full Text] [Related]
24. Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.
Kohan DE; Pollock DM
Br J Clin Pharmacol; 2013 Oct; 76(4):573-9. PubMed ID: 23228194
[TBL] [Abstract][Full Text] [Related]
25. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
Vianna HR; Soares CM; Silveira KD; Elmiro GS; Mendes PM; de Sousa Tavares M; Teixeira MM; Miranda DM; Simões E Silva AC
Pediatr Nephrol; 2013 Mar; 28(3):463-9. PubMed ID: 23161207
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers for early detection of sickle nephropathy.
Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1 response to glucose and insulin among African Americans.
DeLoach S; Huan Y; Daskalakis C; Falkner B
J Am Soc Hypertens; 2010; 4(5):227-35. PubMed ID: 20728421
[TBL] [Abstract][Full Text] [Related]
28. Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.
Caletti MG; Balestracci A; Roy AH
Pediatr Nephrol; 2010 Jun; 25(6):1177-80. PubMed ID: 20157739
[TBL] [Abstract][Full Text] [Related]
29. Accurate measurement and clinical significance of urinary transforming growth factor-beta1.
Tsakas S; Goumenos DS
Am J Nephrol; 2006; 26(2):186-93. PubMed ID: 16679757
[TBL] [Abstract][Full Text] [Related]
30. Urinary endothelin: a possible biological marker of renal damage.
Abassi ZA; Klein H; Golomb E; Keiser HR
Am J Hypertens; 1993 Dec; 6(12):1046-54. PubMed ID: 8136095
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.
Grenda R; Wühl E; Litwin M; Janas R; Sladowska J; Arbeiter K; Berg U; Caldas-Afonso A; Fischbach M; Mehls O; Sallay P; Schaefer F;
Nephrol Dial Transplant; 2007 Dec; 22(12):3487-94. PubMed ID: 17901069
[TBL] [Abstract][Full Text] [Related]
32. Urinary transforming growth factor-β1 in children with obstructive uropathy.
Zieg J; Blahova K; Seeman T; Bronsky J; Dvorakova H; Pechova M; Janda J; Matousovic K
Nephrology (Carlton); 2011 Aug; 16(6):595-8. PubMed ID: 21382126
[TBL] [Abstract][Full Text] [Related]
33. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
34. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Liu BC; Zhang L; Lv LL; Wang YL; Liu DG; Zhang XL
Am J Nephrol; 2006; 26(5):483-90. PubMed ID: 17095863
[TBL] [Abstract][Full Text] [Related]
35. Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children.
Correia-Costa L; Morato M; Sousa T; Cosme D; Guimarães JT; Guerra A; Schaefer F; Afonso AC; Azevedo A; Albino-Teixeira A
Pediatr Nephrol; 2016 Mar; 31(3):455-64. PubMed ID: 26482255
[TBL] [Abstract][Full Text] [Related]
36. Conversion from calcineurin inhibitors to sirolimus in kidney transplant patients reduces the urinary transforming growth factor-beta1 concentration.
Saurina A; Campistol JM; Lario S; Oppenheimer F; Diekmann F
Transplant Proc; 2007 Sep; 39(7):2138-41. PubMed ID: 17889117
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
